Heron Therapeutics is trading at $0.39, down -5.85%, with no direct catalyst identified.
- No new company-specific announcement was identified for October 13, and the company’s press-release listing shows no recent release.
- XBI is down 2.01% during the regular session, offering a possible sector explanation but not confirming the cause; Heron Therapeutics is falling more sharply than the sector.